Sparstolonin B
≥98% (HPLC)
- Product Code: 71273
CAS:
1259330-61-4
| Molecular Weight: | 268.22 g./mol | Molecular Formula: | C₁₅H₈O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Sparstolonin B is primarily recognized for its anti-inflammatory properties, making it a potential therapeutic agent in managing inflammatory diseases. It has shown efficacy in inhibiting the activation of TLR2 and TLR4, which are key receptors involved in the inflammatory response. This makes it a promising candidate for treating conditions like sepsis, atherosclerosis, and other inflammatory disorders. Additionally, research suggests its potential in alleviating neuroinflammation, which could be beneficial in neurodegenerative diseases such as Alzheimer's and Parkinson's. Its ability to modulate inflammatory pathways without significant toxicity further enhances its appeal for future drug development.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to beige to yellow Solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $166.52 |
+
-
|
Sparstolonin B
Sparstolonin B is primarily recognized for its anti-inflammatory properties, making it a potential therapeutic agent in managing inflammatory diseases. It has shown efficacy in inhibiting the activation of TLR2 and TLR4, which are key receptors involved in the inflammatory response. This makes it a promising candidate for treating conditions like sepsis, atherosclerosis, and other inflammatory disorders. Additionally, research suggests its potential in alleviating neuroinflammation, which could be beneficial in neurodegenerative diseases such as Alzheimer's and Parkinson's. Its ability to modulate inflammatory pathways without significant toxicity further enhances its appeal for future drug development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :